Augmented-reality cognitive behavior therapy for fear of contamination in obsessive-compulsive disorder: a protocol for a multicenter randomized controlled trial
Many people with obsessive-compulsive disorder never receive evidence-based treatment, because it is hard to access, expensive or simply not available nearby. This protocol describes a multicenter randomized controlled trial of ZeroOCD, an augmented reality self-help intervention for fear of contamination.
Summary
Obsessive-compulsive disorder (OCD) affects a substantial part of the population and carries a high economic burden. Although effective treatments exist, barriers in accessibility, affordability and scalability mean that many people do not receive them. Augmented reality exposure therapy (ARET) is emerging as a promising alternative to conventional face-to-face therapy.
The trial evaluates ZeroOCD, an AR-based cognitive-behavioral self-help intervention for contamination-related fear with minimal therapist guidance. It is compared with cognitive behavior therapy (CBT) delivered via videoconferencing and with a waitlist control condition. Outcomes are the severity of contamination fear at post-intervention and at 6-month follow-up, cost-effectiveness and user-friendliness.
In total, 189 participants with fear of contamination are recruited from the Dutch-, German- and Swedish-speaking general population (63 per language group). Recruitment and data collection started in September 2025 and continue through 2026. The trial is registered at ClinicalTrials.gov (NCT07194473).
Read more
Reference
Skoko, A., Hlynsson, J. I., Ciharova, M., Berger, T., Carlbring, P., Krieger, T., Bergström, J., Van Daele, T., van Klaveren, C., Cornelisz, I., Andersson, G., & Donker, T. (2026). Augmented-reality cognitive behavior therapy for fear of contamination in obsessive-compulsive disorder: A protocol for a multicenter randomized controlled trial. JMIR Research Protocols. https://doi.org/10.2196/preprints.103262